PremiumCompany AnnouncementsHemogenyx Expands HG-CT-1 Trial to Pediatric Patients Hemogenyx Pharmaceuticals Corrects AGM Notice Error Hemogenyx Pharmaceuticals Secures Funding for Phase 1 Clinical Trials PremiumCompany AnnouncementsHemogenyx Pharmaceuticals Announces Total Voting Rights Update Hemogenyx Pharmaceuticals Announces Total Voting Rights Update Hemogenyx Pharmaceuticals Achieves Milestone with CAR-T Therapy for AML PremiumCompany AnnouncementsHemogenyx Pharmaceuticals Administers First-in-Human Dose of HG-CT-1 for AML Hemogenyx Pharmaceuticals Secures Funding to Advance CAR-T Therapy Trials Hemogenyx Pharmaceuticals Announces Total Share Capital